2019-04-09T11:51:39Z
2019-04-09T11:51:39Z
2018-01-02
2019-04-09T11:51:40Z
The androgen receptor is a transcription factor that plays a key role in the development of prostate cancer, and its interactions with general transcription regulators are therefore of potential therapeutic interest. The mechanistic basis of these interactions is poorly understood due to the intrinsically disordered nature of the transactivation domain of the androgen receptor and the generally transient nature of the protein-protein interactions that trigger transcription. Here, we identify a motif of the transactivation domain that contributes to transcriptional activity by recruiting the C-terminal domain of subunit 1 of the general transcription regulator TFIIF. These findings provide molecular insights into the regulation of androgen receptor function and suggest strategies for treating castration-resistant prostate cancer.
Article
Versió acceptada
Anglès
Càncer de pròstata; Receptors d'hormones; Andrògens; Terapèutica; Prostate cancer; Hormone receptors; Androgens; Therapeutics
Elsevier Ltd
Versió postprint del document publicat a: https://doi.org/10.1016/j.str.2017.11.007
Structure, 2018, vol. 11, num. 9, p. 2499-2505
https://doi.org/10.1016/j.str.2017.11.007
info:eu-repo/grantAgreement/EC/H2020/648201/EU//CONCERT
cc-by-nc-nd (c) Elsevier Ltd, 2018
http://creativecommons.org/licenses/by-nc-nd/3.0/es